dipropyltryptamine

Small moleculeexperimental

N,N-Dipropyltryptamine (DPT) is a psychedelic drug and entheogen belonging to the tryptamine family. Use as a designer drug has been documented by law enforcement officials since as early as 1968. However, potential therapeutic use was not investigated until the 1970s. It is found either as a crystalline hydrochloride salt or as an oily or crystalline base. It has not been found to occur endogenously. It is a close structural homologue of dimethyltryptamine and diethyltryptamine. — Wikipedia

Clinical trial activity

7 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
6
Phase 2
5
Phase 3
1
Phase 4
0

Earliest trial started Apr 1, 2011 (NCT01977196)

Timeline

2010s

  1. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2015

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • dipropyltryptamine
  • dipropyltryptamine
  • dipropyltryptamine
  • dipropyltryptamine hydrochloride
  • dpt
  • dpt

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02584816Phase 3Nov 1, 2015PATH, Serum Institute of India Pvt. Ltd.
NCT02338700Phase 1/Phase 2 (Phase 2)Jan 1, 2015Jinan University
NCT02338752Phase 1/Phase 2 (Phase 2)Jan 1, 2015Jinan University
NCT02338778Phase 1/Phase 2 (Phase 2)Jan 1, 2015Jinan University
NCT02338804Phase 1/Phase 2 (Phase 2)Jan 1, 2015Jinan University
NCT02033707Phase 1Apr 1, 2014Johns Hopkins University
NCT01977196Phase 1Apr 1, 2011PT Bio Farma
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Jinan UniversityAcademic/Hospital4412015
Johns Hopkins UniversityAcademic/Hospital1112014
PATHAcademic/Hospital1012015
PT Bio FarmaFor profit1112011
Serum Institute of India Pvt. Ltd.For profit1112015
5 organizations
Page 1 / 1